1,525
Views
0
CrossRef citations to date
0
Altmetric
Original research

Clusterin protects mature dendritic cells from reactive oxygen species mediated cell death

, , , , , , , , , , & show all
Article: 2294564 | Received 14 Aug 2023, Accepted 08 Dec 2023, Published online: 18 Dec 2023

References

  • Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21(1):685–12. doi:10.1146/annurev.immunol.21.120601.141040.
  • Cabeza-Cabrerizo M, Cardoso A, Minutti CM, Pereira da Costa M, Reis e Sousa C. Dendritic cells revisited. Annu Rev Immunol. 2021;39(1):131–66. doi:10.1146/annurev-immunol-061020-053707.
  • Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24. doi:10.1038/s41577-019-0210-z.
  • Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 2002;20(1):621–667. doi:10.1146/annurev.immunol.20.100301.064828.
  • Pittet MJ, Di Pilato M, Garris C, Mempel TR. Dendritic cells as shepherds of T cell immunity in cancer. Immunity. 2023;56(10):2218–2230. doi:10.1016/j.immuni.2023.08.014.
  • Chen M, Wang J. Programmed cell death of dendritic cells in immune regulation. Immunol Rev. 2010;236(1):11–27. doi:10.1111/j.1600-065X.2010.00916.x.
  • Kushwah R, Hu J. Dendritic cell apoptosis: regulation of tolerance versus immunity. J Immunol. 2010;185(2):795–802. doi:10.4049/jimmunol.1000325.
  • Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Sci. 2006;311(5764):1160–4. doi:10.1126/science.1122545.
  • Chen M. Regulation of immune responses by spontaneous and T cell-mediated dendritic cell death. J Clin Cell Immunol. 2011;1(S3):S3. doi:10.4172/2155-9899.S3-005.
  • Kubicka-Sierszen A, Grzegorczyk JL. The influence of infectious factors on dendritic cell apoptosis. Arch Med Sci. 2015;11(5):1044–51. doi:10.5114/aoms.2015.54860.
  • Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002;34(5):427–31. doi:10.1016/S1357-2725(01)00155-8.
  • Wilson MR, Zoubeidi A. Clusterin as a therapeutic target. Expert Opin Ther Targets. 2017;21(2):201–213. doi:10.1080/14728222.2017.1267142.
  • Rizzi F, Coletta M, Bettuzzi S. Chapter 2: clusterin (CLU): from one gene and two transcripts to many proteins. Adv Cancer Res. 2009;104:9–23.
  • Merlotti A, Dantas E, Remes Lenicov F, Ceballos A, Jancic C, Varese A, Rubione J, Stover S, Geffner J, Sabatté J, et al. Fucosylated clusterin in semen promotes the uptake of stress-damaged proteins by dendritic cells via DC-SIGN. Hum Reprod. 2015;30(7):1545–1556. doi:10.1093/humrep/dev113.
  • Sabatte J, Faigle W, Ceballos A, Morelle W, Rodriguez Rodrigues C, Remes Lenicov F, Thépaut M, Fieschi F, Malchiodi E, Fernández M, et al. Semen clusterin is a novel DC-SIGN ligand. J Immunol. 2011;187(10):5299–5309. doi:10.4049/jimmunol.1101889.
  • Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR. Extracellular chaperones and proteostasis. Annu Rev Biochem. 2013;82(1):295–322. doi:10.1146/annurev-biochem-072711-163904.
  • Tschopp J, French LE. Clusterin: modulation of complement function. Clin Exp Immunol. 1994;97(Suppl Supplement_2):11–4. doi:10.1111/j.1365-2249.1994.tb06256.x.
  • Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer’s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 2019;13:164. doi:10.3389/fnins.2019.00164.
  • Satapathy S, Wilson MR. Roles of constitutively secreted extracellular chaperones in neuronal cell repair and regeneration. Neural Regen Res. 2023;18(4):769–72. doi:10.4103/1673-5374.353483.
  • Garcia-Aranda M, Tellez T, Munoz M, Redondo M. Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer. Anticancer Drugs. 2017;28(7):702–716. doi:10.1097/CAD.0000000000000507.
  • Ammar H, Closset JL. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2008;283(19):12851–12861. doi:10.1074/jbc.M800403200.
  • Trougakos IP, Djeu JY, Gonos ES, Boothman DA. Advances and challenges in basic and translational research on clusterin. Cancer Res. 2009;69(2):403–406. doi:10.1158/0008-5472.CAN-08-2912.
  • Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY. Clusterin inhibits apoptosis by interacting with activated bax. Nat Cell Biol. 2005;7(9):909–915. doi:10.1038/ncb1291.
  • Zhang F, Kumano M, Beraldi E, Fazli L, Du C, Moore S, Sorensen P, Zoubeidi A, Gleave ME. Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat Commun. 2014;5(1):5775. doi:10.1038/ncomms6775.
  • Satoh T, Manel N. Gene transduction in human monocyte-derived dendritic cells using lentiviral vectors. Meth Mol Biol. 2013;960:401–9.
  • Tchasovnikarova IA, Timms RT, Matheson NJ, Wals K, Antrobus R, Gottgens B, Dougan G, Dawson MA, Lehner PJ. GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells. Sci. 2015;348(6242):1481–5. doi:10.1126/science.aaa7227.
  • Rohne P, Prochnow H, Koch-Brandt C. The CLU-files: disentanglement of a mystery. Biomol Concepts. 2016;7(1):1–15. doi:10.1515/bmc-2015-0026.
  • Herring SK, Moon HJ, Rawal P, Chhibber A, Zhao L. Brain clusterin protein isoforms and mitochondrial localization. eLife. 2019;8. doi:10.7554/eLife.48255.
  • Martínez D, Vermeulen M, von Euw E, Sabatte J, Maggíni J, Ceballos A, Trevani A, Nahmod K, Salamone G, Barrio M, et al. Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol. 2007;179(3):1950–9. doi:10.4049/jimmunol.179.3.1950.
  • Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004;5(8):825–830. doi:10.1038/sj.embor.7400205.
  • Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792–809.e23. doi:10.1016/j.cell.2021.01.010.
  • Kvedaraite E, Ginhoux F. Human dendritic cells in cancer. Sci Immunol. 2022;7(70):eabm9409. doi:10.1126/sciimmunol.abm9409.
  • Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, Chudnovskiy A, Maskey S, Walker L, Finnigan JP, et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 2020;580(7802):257–262. doi:10.1038/s41586-020-2134-y.
  • Leader AM, Grout JA, Maier BB, Nabet BY, Park MD, Tabachnikova A, Chang C, Walker L, Lansky A, Le Berichel J, et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell. 2021;39(12):1594–1609.e12. doi:10.1016/j.ccell.2021.10.009.
  • Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179(4):829–845.e20. doi:10.1016/j.cell.2019.10.003.
  • Tang-Huau TL, Gueguen P, Goudot C, Durand M, Bohec M, Baulande S, Pasquier B, Amigorena S, Segura E. Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway. Nat Commun. 2018;9(1):2570. doi:10.1038/s41467-018-04985-0.
  • Dumont P, Chainiaux F, Eliaers F, Petropoulou C, Remacle J, Koch-Brandt C, Gonos ES, Toussaint O. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones. 2002;7(1):23–35. doi:10.1379/1466-1268(2002)007<0023:OOAJIH>2.0.CO;2.
  • Miyake H, Hara I, Gleave ME, Eto H. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. The Prostate. 2004;61(4):318–323. doi:10.1002/pros.20087.
  • Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME, Oeda J, Masayasu H, Takashima A. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol. 2003;171(6):3010–8. doi:10.4049/jimmunol.171.6.3010.
  • Del Prete A, Zaccagnino P, Di Paola M, Saltarella M, Oliveros Celis C, Nico B, Santoro G, Lorusso M. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radical Biol Med. 2008;44(7):1443–51. doi:10.1016/j.freeradbiomed.2007.12.037.
  • Yamada H, Arai T, Endo N, Yamashita K, Fukuda K, Sasada M, Uchiyama T. LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells. Life Sci. 2006;78(9):926–33. doi:10.1016/j.lfs.2005.05.106.
  • Paardekooper LM, Vos W, van den Bogaart G. Oxygen in the tumor microenvironment: effects on dendritic cell function. Oncotarget. 2019;10(8):883–896. doi:10.18632/oncotarget.26608.
  • Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22(5):280–297. doi:10.1038/s41568-021-00435-0.
  • Hou WS, Van Parijs L. A bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol. 2004;5(6):583–589. doi:10.1038/ni1071.
  • Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, Rocchetti M, Mingozzi F, Foti M, Chirico G, et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature. 2009;460(7252):264–268. doi:10.1038/nature08118.
  • Paardekooper LM, Dingjan I, Linders PTA, Staal AHJ, Cristescu SM, Verberk W, van den Bogaart G. Human monocyte-derived dendritic cells produce millimolar concentrations of ROS in phagosomes per second. Front Immunol. 2019;10:1216. doi:10.3389/fimmu.2019.01216.
  • Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479–496. doi:10.3109/10715761003667554.
  • Pereira RM, Mekary RA, da Cruz Rodrigues KC, Anaruma CP, Ropelle ER, da Silva ASR, Cintra DE, Pauli JR, de Moura LP. Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes. Heart Fail Rev. 2018;23(1):123–9. doi:10.1007/s10741-017-9654-z.
  • Rodriguez-Rivera C, Garcia MM, Molina-Alvarez M, Gonzalez-Martin C, Goicoechea C. Clusterin: always protecting. Synthesis, function and potential issues. Biomed Pharmacother. 2021;134:111174. doi:10.1016/j.biopha.2020.111174.
  • Magen A, Hamon P, Fiaschi N, Soong BY, Park MD, Mattiuz R, Humblin E, Troncoso L, D’souza D, Dawson T, et al. Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat Med. 2023;29(6):1389–1399. doi:10.1038/s41591-023-02345-0.
  • Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487–500. doi:10.1038/s41590-022-01132-2.
  • Zhang Y, Lv X, Chen L, Liu Y. The role and function of CLU in cancer biology and therapy. Clin Exp Med. 2023;23(5):1375–91. doi:10.1007/s10238-022-00885-2.
  • Segura E. Human dendritic cell subsets: an updated view of their ontogeny and functional specialization. Eur J Immunol. 2022;52(11):1759–1767. doi:10.1002/eji.202149632.
  • Koltai T. Clusterin: a key player in cancer chemoresistance and its inhibition. OncoTargets Ther. 2014;7:447–456. doi:10.2147/OTT.S58622.
  • Muhammad LA, Saad F. The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target. Expert Rev Anticancer Ther. 2015;15(9):1049–1061. doi:10.1586/14737140.2015.1064769.
  • Mazzarelli P, Pucci S, Spagnoli LG. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype. Adv Cancer Res. 2009;105:45–61.
  • Panico F, Casali C, Rossi G, Rizzi F, Morandi U, Bettuzzi S, Davalli P, Corbetta L, Storelli ES, Corti A, et al. Prognostic role of clusterin in resected adenocarcinomas of the lung. Lung Cancer. 2013;79(3):294–299. doi:10.1016/j.lungcan.2012.11.024.
  • Rizzi F, Bettuzzi S. The clusterin paradigm in prostate and breast carcinogenesis. Endocr Relat Cancer. 2010;17(1):R1–17. doi:10.1677/ERC-09-0140.
  • Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, Thomas-Tikhonenko A. Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res. 2009;105:115–32.
  • Tellez T, Martin-Garcia D, Redondo M, Garcia-Aranda M. Clusterin expression in colorectal carcinomas. Int J Mol Sci. 2023;24(19):14641. doi:10.3390/ijms241914641.